middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viru
great
global
public
health
concern
initi
recognit
saudi
arabia
august
patient
confirm
merscov
infect
includ
death
report
world
health
organ
countri
dromedari
camel
known
sourc
human
infect
viru
enzoot
dromedari
arabian
peninsula
middl
east
mani
region
africa
well
pakistan
bangladesh
global
popul
infect
dromedari
found
africa
includ
morocco
although
travelassoci
case
report
sever
countri
zoonot
mer
case
report
arabian
peninsula
middl
east
reason
appar
absenc
zoonot
mer
africa
spite
exposur
virusinfect
dromedari
unclear
like
sever
factor
may
owe
genet
phenotyp
differ
viru
strain
circul
africa
behaviour
factor
relat
pattern
exposur
altern
mer
detect
assumpt
zoonot
mer
occur
africa
may
lead
lack
test
merscov
human
regular
contact
dromedari
arabian
peninsula
higher
seropreval
merscov
gener
popul
thu
far
limit
number
serolog
studi
conduct
peopl
intens
exposur
merscovinfect
camel
africa
studi
howev
import
better
understand
geograph
extent
merscov
infect
human
popul
camelexpos
abattoir
worker
nigeria
serolog
evid
merscov
infect
despit
intens
exposur
merscov
infect
camel
similarli
peopl
contact
camel
kenya
egypt
serolog
evid
merscov
infect
anoth
kenyan
studi
individu
without
direct
occup
exposur
dromedari
camel
found
two
individu
low
level
neutralis
antibodi
merscov
knowledg
known
instanc
merscov
seroposit
human
africa
prior
studi
morocco
recent
studi
merscov
show
seropreval
rang
viral
rna
shed
rate
rang
among
dromedari
southern
morocco
region
countri
highest
densiti
dromedari
camel
peopl
live
region
share
close
cultur
econom
bond
dromedari
also
consum
dromedari
milk
meat
product
mani
peopl
close
repetit
contact
dromedari
includ
slaughterhous
worker
camel
market
worker
camel
herder
sinc
inform
merscov
infect
human
morocco
aim
studi
determin
merscov
seropreval
among
presum
highrisk
popul
peopl
close
contact
dromedari
say
live
camel
herd
area
includ
individu
occup
exposur
dromedari
administr
region
guelmim
noun
el
hamra
dakhlaou
eddahab
select
studi
dromedari
camel
morocco
three
region
popul
region
consid
highrisk
merscov
infect
direct
indirect
contact
dromedari
studi
purpos
divid
three
categori
camel
herder
slaughterhous
worker
occup
exposur
gener
popul
ie
individu
live
highrisk
area
direct
occup
contact
dromedari
human
blood
sampl
collect
carri
month
novemb
januari
conveni
sampl
strategi
use
sampl
differ
risk
group
led
blood
sampl
collect
camel
herder
camel
slaughterhous
abattoir
worker
individu
gener
popul
particip
provid
sign
inform
consent
administ
detail
questionnair
elicit
demograph
inform
well
inform
food
habit
durat
type
exposur
camel
histori
respiratori
symptom
camel
herder
abattoir
worker
use
person
protect
equip
boot
coveral
mask
glove
coat
hygien
practic
also
elicit
two
hundr
agestratifi
sera
collect
blood
donor
hong
kong
age
year
known
exposur
dromedari
camel
use
control
human
sera
test
merscov
igg
antibodi
use
merscov
spike
elisa
ei
g
kit
euroimmun
germani
accord
manufactur
instruct
medic
virolog
laboratori
institut
pasteur
du
maroc
casablanca
morocco
extinct
valu
calibr
includ
test
defin
upper
limit
refer
rang
noninfect
human
valu
set
cutoff
elisa
made
semiquantit
calcul
ratio
extinct
valu
serum
sampl
extinct
valu
calibr
manufactur
recommend
cutoff
ratio
interpret
neg
borderlin
posit
subsequ
public
suggest
lower
elisa
cutoff
ratio
screen
purpos
select
sera
confirm
neutralis
test
also
includ
elisa
optic
densiti
od
ratio
analysi
sera
also
screen
triplic
merscov
pseudoparticl
neutralis
test
ppnt
describ
previous
sera
posit
ppnt
screen
dilut
titrat
endpoint
ppnt
assay
well
plaqu
reduct
neutralis
test
prnt
conduct
contain
endpoint
ppnt
assay
highest
serum
dilut
give
reduct
luciferas
signal
compar
neg
control
endpoint
prnt
highest
serum
dilut
gave
reduct
viru
plaqu
compar
control
method
describ
elsewher
seraposit
titr
ppnt
assay
regard
posit
seraposit
titr
ppnt
neg
assay
regard
borderlin
posit
neutralis
result
sera
regard
neg
statist
signific
serolog
posit
exposur
group
analys
use
chisquar
test
yate
correct
statist
signific
defin
p
studi
approv
nation
ethic
committe
biomed
research
cerb
moham
v
de
et
de
pharmaci
de
rabat
refer
number
agestratifi
sera
hong
kong
blood
donor
previous
obtain
part
studi
use
control
anonymis
use
sera
seroepidemiolog
studi
approv
univers
hong
kong
hospit
author
hong
kong
west
institut
review
board
uw
sampl
collect
total
peopl
femal
male
tabl
studi
particip
year
age
rang
came
guelmim
noun
region
el
hamra
region
dakhlaou
eddahab
region
maletofemal
ratio
camel
herder
slaughterhous
worker
gener
popul
tabl
direct
indirect
exposur
pattern
dromedari
dromedari
product
raw
camel
meat
camel
urin
unpasteuris
camel
milk
studi
subject
summaris
tabl
consumpt
raw
camel
meat
unpasteur
camel
milk
uncommon
three
group
rang
respect
tabl
none
particip
histori
sever
pneumonia
requir
hospit
admiss
none
travel
outsid
morocco
camel
herder
n
least
year
travel
nomad
dromedari
herd
mani
month
year
contact
camel
around
home
rest
year
herder
camel
herd
also
sheep
goat
within
herd
task
herd
includ
clean
care
anim
n
feed
milk
market
supplement
task
n
herder
report
contact
dromedari
wast
n
contact
ill
n
dead
n
dromedari
directli
handl
dromedari
die
ill
n
person
protect
gear
eg
boot
coveral
mask
coat
use
herder
slaughterhous
worker
n
work
dromedari
slaughterhous
least
year
work
hour
hour
per
day
day
per
week
uniformli
occup
contact
camel
slaughterhous
n
also
dromedari
around
home
tabl
work
includ
slaughter
clean
slaughterhous
store
camel
meat
directli
involv
slaughter
involv
clean
transport
product
secur
person
protect
gear
usual
report
boot
glove
mask
use
slaughterhous
worker
twentytwo
regularli
live
slept
slaughterhous
least
week
gener
popul
group
n
dromedari
around
home
direct
recurr
contact
dromedari
frequent
consum
raw
camel
meat
consum
unpasteuris
camel
milk
per
week
test
human
sera
antimerscov
igg
antibodi
elisa
use
elisa
kit
recommend
cutoff
sera
reactiv
od
ratio
borderlin
reactiv
od
ratio
tabl
use
lower
screen
cutoff
recommend
muller
et
al
addit
sera
would
regard
suspect
posit
requir
test
neutralis
test
test
sera
irrespect
elisa
result
merscov
neutralis
activ
use
ppnt
assay
three
posit
ppnt
titr
one
posit
ppnt
titr
tabl
two
posit
elisa
od
ratio
cutoff
one
borderlin
od
ratio
neg
od
ratio
per
kit
instruct
would
recommend
confirmatori
test
algorithm
use
muller
et
al
four
ppntposit
sera
dilut
three
confirm
reactiv
regard
confirm
neutralis
sera
one
ppnt
elisa
od
ratio
reduc
plaqu
number
ie
posit
regard
borderlin
neutralis
confirmatori
test
tabl
sera
hong
kong
serv
neg
control
neg
assay
valid
ppnt
test
neg
control
sera
previous
report
sera
posit
borderlin
elisa
ie
od
ratio
neg
ppnt
sera
neg
test
signific
associ
result
two
test
chisquar
yate
correct
p
howev
scatterplot
elisa
ppnt
assay
reveal
high
level
correl
correl
coeffici
rvalu
ci
figur
consid
sera
posit
screen
ppnt
assay
confirm
true
merscov
posit
sera
elisa
cut
recommend
manufactur
sensit
posit
predict
valu
ppv
serum
borderlin
prnt
activ
also
borderlin
elisa
reactiv
lower
od
ratio
use
cutoff
select
sera
confirmatori
test
recommend
mueller
et
al
sensit
elisa
screen
sera
subsequ
confirm
posit
borderlin
neutralis
posit
ppv
nine
slaughterhous
worker
three
camel
herder
eight
peopl
gener
popul
merscov
antibodyposit
elisa
test
use
elisa
kit
recommend
cutoff
valu
tabl
three
slaughterhous
worker
none
camel
herder
one
peopl
gener
popul
merscov
neutralis
antibodi
posit
ppnt
assay
four
merscov
neutralis
antibodyposit
sera
also
reduc
viru
plaqu
number
three
reduc
plaqu
count
tabl
statist
signific
associ
exposur
group
merscov
seroposit
either
elisa
neutralis
test
note
group
resid
camel
herd
area
like
exposur
camel
camel
product
three
camel
slaughterhous
worker
confirm
n
borderlin
n
neutralis
seroposit
merscov
male
age
year
work
camel
slaughterhous
year
regularli
consum
camel
urin
one
regularli
consum
unpasteuris
camel
milk
raw
camel
meat
addit
tabl
one
person
gener
popul
group
seroposit
merscov
femal
diabet
hypertens
direct
contact
camel
other
household
regular
contact
camel
least
week
consum
camel
urin
raw
unpasteuris
camel
milk
tabl
studi
provid
first
serolog
evid
merscov
infect
human
morocco
anywher
north
west
africa
viru
use
serolog
emc
strain
merscov
previous
shown
antigen
differ
merscov
strain
emc
virus
africa
result
suggest
evid
human
infect
two
slaughterhous
worker
confirm
merscov
neutralis
antibodi
one
addit
slaughterhous
worker
borderlin
neutralis
activ
one
person
gener
popul
live
camel
herd
area
confirm
neutralis
antibodi
femal
gener
popul
group
confirm
serum
merscov
neutralis
activ
occup
direct
contact
camel
other
household
regularli
consum
camel
urin
unpasteuris
camel
milk
role
camel
product
camel
milk
urin
transmiss
merscov
previous
rais
remain
unclear
none
seroposit
peopl
travel
outsid
morocco
suggest
infect
acquir
local
none
merscov
antibodi
histori
sever
pneumonia
common
featur
sever
mer
surpris
serolog
studi
saudi
arabia
qatar
detect
infect
peopl
histori
merslik
diseas
known
merscov
infect
may
rang
asymptomat
sever
pneumonia
acut
respiratori
distress
syndrom
ard
death
mild
asymptomat
infect
may
contribut
onward
transmiss
camel
herder
includ
studi
none
confirm
serum
merscov
neutralis
activ
although
previous
found
merscov
circul
camel
region
possibl
herder
lower
risk
slaughterhous
worker
camel
brought
slaughterhous
often
transit
via
camel
market
mix
camel
divers
sourc
allow
amplif
viru
circul
may
result
higher
rate
viru
shed
greater
merscov
exposur
slaughterhous
worker
three
peopl
confirm
merscov
neutralis
antibodi
ppnt
titr
titr
unexpect
even
patient
confirm
merscov
diseas
invari
mount
robust
neutralis
elisa
antibodi
titr
unless
sever
pneumonia
thu
peopl
mild
infect
may
low
undetect
antibodi
titr
merscov
furthermor
antibodi
may
wane
time
serolog
may
thu
consider
underestim
extent
mild
asymptomat
merscov
infect
previous
suggest
recent
studi
propos
supplement
serolog
merscovspecif
tcell
respons
may
identifi
addit
individu
prior
merscov
infect
popul
base
studi
previous
publish
data
human
merscov
seropreval
arabian
peninsula
africa
pakistan
summaris
supplementari
tabl
arabian
peninsula
aggreg
peopl
occup
expos
dromedari
test
neutralis
test
merscov
antibodi
seven
studi
found
seroposit
aggreg
human
sera
peopl
occup
expos
dromedari
previous
test
africa
egypt
kenya
nigeria
seroposit
detect
peopl
seroposit
present
studi
gener
popul
merscov
seropreval
arabian
peninsula
aggreg
person
sampl
peopl
test
kenya
africa
peopl
present
studi
morocco
see
supplementari
tabl
inform
signific
associ
overal
result
neutralis
mer
elisa
test
detect
antibodi
merscov
human
correl
two
method
poor
sensit
elisa
use
kit
recommend
cutoff
though
lower
elisa
od
ratio
suggest
muller
et
al
use
howev
posit
predict
valu
merscov
antibodi
elisa
poor
either
cutoff
use
popul
seroepidemiolog
similar
result
report
saudi
arabia
need
consid
plan
human
seropreval
studi
conclus
found
evid
zoonot
transmiss
merscov
morocco
support
previou
data
kenya
indic
merscov
capabl
zoonot
infect
africa
howev
yet
known
merscov
circul
africa
caus
zoonot
diseas
ie
invad
lower
respiratori
tract
caus
sever
viral
pneumonia
genet
divers
strain
merscov
found
moroccan
dromedari
well
region
western
africa
eg
nigeria
burkina
faso
might
lower
potenti
sever
zoonot
diseas
compar
viru
strain
isol
middl
east
test
merscov
rna
patient
sever
acut
respiratori
infect
dromedari
camel
herd
region
africa
need
ascertain
whether
zoonot
mer
diseas
occur
africa
